Jump to content

Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Targeting Focal Adhesion Kinase (FAK) in Fibrotic Diseases.

  • Please log in to reply
No replies to this topic

#1 Joelf


    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,616 posts
  • Location:West Sussex

Posted 21 February 2013 - 02:17 PM

Targeting Focal Adhesion Kinase (FAK) in Fibrotic Diseases.

Recent findings suggest that FAK plays a key role in development offibrotic disorders, and it appears to be an attractive target forantifibrotic therapy and has potential as a future therapeutic target to
counteract fibrosis. PubMed, BioDrugs. 2012 Nov 27. (Also see: Pulmonary Fibrosis Research)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)